.AstraZeneca has actually discussed an early examine the performance of its internal antibody-drug c...
.After declaring a period 3 launch based on favorable midstage end results, iTeos and also GSK are l...
.The FDA needs to be extra open and also joint to release a surge in commendations of uncommon ailme...
.It is actually an uncommonly hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...
.Atea Pharmaceuticals' antiviral has failed one more COVID-19 test, yet the biotech still keeps out ...
.Neurocrine Biosciences' mental illness program pivot has actually stopped working. The biotech was ...
.Sanofi has actually created an overdue access to the radioligand event, paying for one hundred mill...
.After F2G's 1st effort to obtain a new course of antifungal to market was thwarted by the FDA, the ...
.Moderna has vowed to cut R&D costs through $1.1 billion through 2027. The choice to shrink the b...
.Simply 4 months after Sanofi wager $80 million in ahead of time money on Key Rehabs' losmapimod, th...